Two homeopathic drugs, Sepia officinalis and Lachesis mutus will be compare for its uses in menopausal syndrome in women

Comparative study of Homeopathic medicine Sepia officinalis and Lachesis mutus in the treatment of Menopausal syndrome - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/097057

Enrollment

Registered

2025-11-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

Intervention1: HOMOEOPATHIC MEDICINE Lachesis Mutus : 30 patient who are suffering from menopause syndrome will be given Lachesis Mutus in the form of medicated homeopathic globues Intervention2: HOM

Eligibility

Inclusion criteria

Inclusion criteria: Diagnostic criteria are mainly based on the clinical presentation. Diagnosed cases of Menopausal syndrome, taking treatment from other system of medicine, feeling no relief or recurrence and seeking HOMOEOPATHIC treatment. Undiagnosed cases of Menopausal syndrome, seeking HOMOEOPATHIC treatment.

Exclusion criteria

Exclusion criteria: Cases with complication like malignancy Patient with pan hysterectomy. Patient with advance pathology. Patient with psychiatric illness. Women using any medicine which contains estrogen and progestin.

Design outcomes

Primary

Measure	Time frame
To compare the efficiency of lachesis mutus and sepia officinalis in treatment of menopausal syndromeTimepoint: 12 months	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDrMihir Upadhyay

S.S.Agrawal Homeopathic Medical College and General Hospital, Navasari

mihiru79@gmail.com9879093337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026